etoposide has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajtner, E; Holmdahl, R; Jonsson, IM; Tarkowski, A; Verdrengh, M; Zaether, O | 1 |
| Isaksson, O; Tarkowski, A; Verdrengh, M | 1 |
2 other study(ies) available for etoposide and Adjuvant Arthritis
| Article | Year |
|---|---|
Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist.
Topics: Animals; Antibodies, Monoclonal; Arthritis, Experimental; Arthritis, Rheumatoid; B-Lymphocytes; Collagen Type II; Disease Models, Animal; Enzyme Inhibitors; Etoposide; Female; Immunization; Interferon-gamma; Interleukin-6; Lymph Nodes; Mice; Mice, Inbred DBA; Topoisomerase II Inhibitors | 2002 |
Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen Type II; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Immunization; Immunosuppressive Agents; Interleukin-6; Male; Mice; Mice, Inbred DBA; Mitoxantrone; Nucleic Acid Synthesis Inhibitors; Topoisomerase II Inhibitors | 2005 |